2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$127.52-$0.29 (-0.23%)
Price as of Aug 21, 2026 7:55 PM EDT- $25.9BMarket Cap
- 50.29%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$127.52-$0.29 (-0.23%)
INCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $127.81 | ||
Change | +$0.59 (+0.46%) | ||
Open | $126.45 | ||
High | $129.92 | ||
Low | $125.60 | ||
Previous Close | $127.22 | ||
Volume | 1,367,411 | ||
30-Day Average Volume | 1,778,519 | ||
1-Week Change | 6.37% | ||
1-Month Change | 8.88% | ||
1-Year Change | 50.29% | ||
3-Year Change | 96.99% | ||
5-Year Change | 70.64% | ||
Fundamentals | |||
Shares Outstanding | 202.7M | ||
Total Assets | $7.9B | ||
Market Cap | $25.9B | ||
Enterprise Value | $21.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $585.6M | ||
Free Cash Flow | $507.7M | ||
EBIT | $751.5M | ||
EBITDA | $778.0M | ||
Net Working Capital | $4.7B | ||
EPS | $2.81 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | 45 | ||
PEG | 0 | ||
Price/Free Cash Flow | 51 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue